Pea

Gencor aims to ‘even the playing field’ with solutions for female athletes

05-Feb-2024 By Olivia Haslam

Researching women's health is like "opening a can of worms" but is imperative for equality in sports and nutrition, says Mariko Hill, global innovations manager at Gencor.

Levagen+ PEA now available for beauty applications

22-Aug-2023 By Cassandra Stern & Danielle Masterson

Gencor’s branded PEA can now be found in the beauty category for its ability to aid in a healthy inflammatory response and protect from oxidative stress-induced damage.

Study explores power of Palmitoylethanolamide in managing pain

17-Oct-2022 By Asia Sherman

Palmitoylethanolamide (PEA) reduces sensitivity to pain in the central and peripheral nervous systems and increases pain modulation, says a recent study from Austrian researchers.

Palmitoylethanolamide a viable, non-toxic alternative to cannabidiols, say scientists

19-Jan-2022 By Nicola Gordon-Seymour

Palmitoylethanolamide (PEA) is a safer and more pervasive therapeutic alternative to cannabidiol, say the authors of the Gencor Pacific-commissioned review, ‘Palmitoylethanolamide: A Potential Alternative to Cannabidiol.’

Effect of ‘super pea’ on gut may benefit those at risk of diabetes, study claims

27-Oct-2020 By Will Chu

A wrinkled type of ‘super pea,’ containing higher levels of gut-friendly ‘resistant starch,’ may prove beneficial to those at risk of type 2 diabetes, due to its ability to control blood sugar levels, a study thinks.

PEA supplement the next big thing in eSports, says Gencor

23-Sep-2020 By Nikki Hancocks

A Palmitoylethanolamide (PEA) supplement matches the efficacy of ibuprofen for reducing pain severity and duration of headaches creating an exciting opportunity within the eSports category, says Gencor.